Similar Articles |
|
Managed Care March 2004 Christine A. Sorkness |
IgE-Blocking Therapy for Difficult-to-Treat Asthma: A Brief Review Omalizumab, a novel therapy that targets specific steps in the inflammatory cascade of asthma, may benefit the hard-to-treat patient. |
American Family Physician January 15, 2005 Liya Davydov |
STEPS - New Drug Reviews Omalizumab is an immunomodulatory therapy for the control of symptoms in patients with moderate to severe allergic asthma uncontrolled with conventional therapy. |
Nurse Practitioner April 2010 Benninger & McCallister |
Asthma in pregnancy: Reading between the lines Asthma is one of the most common, chronic medical conditions that can complicate pregnancy, affecting between 4% and 8% of this population. |
American Family Physician September 15, 2004 Matthew Mintz |
Asthma Update Part II. Medical Management An evidence-based approach was used to examine several key issues on appropriate medical therapy for patients with asthma. The updated guidelines clarify these issues and should alter the way physicians prescribe asthma medications. |
American Journal of Nursing May 2010 Corbridge & Corbridge |
Asthma in Adolescents and Adults This article outlines current guideline recommendations for asthma and reviews what clinicians need to teach patients about its pathophysiology, pharmacotherapy, self monitoring, and environmental control. |
American Family Physician May 15, 2005 Courtney et al. |
Childhood Asthma: Treatment Update The prevalence of childhood asthma has risen significantly over the past four decades. This article summarizes the treatment of asthma in children, with an emphasis on new modalities and the results of recent studies. |
The Motley Fool August 31, 2007 Brian Orelli |
Guidelines to Stop the Wheezing Investors, new asthma guidelines will affect some drug makers. The FDA isn't the only organization that affects how well drugs do in the marketplace. |
American Family Physician September 1, 2004 Matthew Mintz |
Asthma Update: Part I. Diagnosis, Monitoring, and Prevention of Disease Progression The National Asthma Education and Prevention Program Expert Panel has updated its clinical guidelines on asthma medications, prevention of disease progression, and patient self-management. |
AskMen.com June 22, 2003 Mike Davison |
Asthma: Are You At Risk? The recurrent and debilitating effects of asthma sometimes appear suddenly, so it is best to arm yourself with knowledge about this serious and chronic condition. |
Nurse Practitioner December 2010 Kathy J. Morris |
Management of Exercise-Induced Bronchospasm in Adolescents with Asthma Collaboration between the nurse practitioner and adolescent is essential to develop an asthma management plan that will provide for optimal physical activity and prevent asthma exacerbations while exercising. |
American Family Physician April 1, 2001 James P. Kemp & Judith A. Kemp |
Management of Asthma in Children The prevalence of asthma in children has increased 160 percent since 1980, and the disease currently affects nearly 5 million children in the United States... |
Managed Care June 2004 |
Use of Attention-Deficit Medications Surges 369 Percent in Children Under 5 ADHD medication spending for pediatric patients outpaces antibiotics, allergy, and asthma treatments. |
The Motley Fool July 18, 2005 Karl Thiel |
Stocks That Make You Breathe Easier Allergies and asthma are big markets that several firms aim to tackle. Investors, take note. |
Chemistry World August 9, 2012 |
Bapineuzunab dropped Pfizer and Johnson and Johnson have announced that they are ending development of the intravenous Alzheimer's drug bapineuzumab after it failed in two clinical trials. |
The Motley Fool March 21, 2007 Brian Lawler |
New Indication for Pain Pain Therapeutics brings a new drug into the clinic. When drug companies attempt to bring new drugs that are outside of their core competencies to market, investors always need to be wary. |
American Family Physician January 1, 2007 Scow et al. |
Leukotriene Inhibitors in the Treatment of Allergy and Asthma Approximately one third of all prescriptions for maintenance therapy in patients with persistent asthma are for leukotriene inhibitors; however, evidence of their effectiveness compared with other treatments is mixed. |
Chemistry World August 29, 2014 Sarah Houlton |
Roche to buy InterMune for respiratory boost Roche is to acquire InterMune in a deal worth $8.3 billion. |
BusinessWeek November 21, 2005 Catherine Arnst |
How To Manage Your Asthma Asthma sufferers can achieve near-perfect freedom from shortness of breath. |
American Family Physician March 1, 2003 James C. Higgins |
The 'Crashing Asthmatic' Asthma is one of the most common chronic disorders managed by family physicians. A "crashing asthmatic" is a patient with asthma who is clinically deteriorating into respiratory failure or arrest despite initial treatment. Managing such a patient can be a major challenge. |
Real Travel Adventures September 2008 Gary Niemann |
Oral Allergy Immunotherapy In Denver Oral allergy immunotherapy utilizing a potency-enhancing liquid vehicle is painless, convenient, effective, safe, and economical, and can offer relief for millions of allergy sufferers |
Real Travel Adventures February 2008 Bonnie Neely |
Simple Oral Therapy In Denver Prevents Allergic Symptoms For Life! The Allergy Clinic makes patients comfortable again by eliminating their allergic symptoms through simple daily oral drops. |
Nursing June 2011 Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck |
From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition? |
Chemistry World September 25, 2013 Phillip Broadwith |
New respiratory drugs neck and neck A flurry of regulatory approvals has seen three new drugs approved for asthma and chronic obstructive pulmonary disease in the European and Japanese markets. |
American Family Physician August 15, 2002 James T. Li |
Allergy Testing Allergic diseases are among the most common medical problems encountered in ambulatory practice. Allergy testing can help the physician determine if a patient's problem is caused by an allergy and identify the specific problem allergens. |
Nursing November 2011 Lawson & Pruitt |
Issues in Obesity, Part 2: Obesity Weighs Heavily on Lung Function A look at the impact of obesity on asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. |
American Family Physician December 1, 2001 Sami Youakim |
Work-Related Asthma Work-related asthma is induced or incited by substances or conditions specific to the workplace. It has become the most common occupational respiratory disease in many countries... |
American Family Physician April 1, 2001 |
Take Control of Your Asthma What is asthma?... How can I control my asthma?... |
American Family Physician May 15, 2005 |
Treating My Child's Asthma An informative hand-out aimed at the primary care-giver of an asthmatic child. |
American Family Physician March 15, 2001 |
Asthma Medications |
Managed Care March 2005 Frank Diamond |
Kaiser's Asthma Outcomes Will Take Your Breath Away The company's Mid-Atlantic States Region has seen impressive savings since launching a disease management program for asthma. |
Chemistry World July 25, 2006 Bea Perks |
Clinical Chaos Under Scrutiny Clinical trials of new drugs need to be tightened up, according to an expert group convened in the aftermath of UK trials that left six people fighting for their lives. |
American Family Physician August 1, 2002 |
Things That Can Cause Asthma and Allergies Dust mites... Pets... Cockroaches... Pollens and outdoor molds... Indoor molds... Air pollution... |